KeyBank National Association’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.76M | Buy |
52,676
+14,506
| +38% | +$767K | 0.01% | 414 |
|
|
2026
Q1 | $2.11M | Buy |
38,170
+12,784
| +50% | +$693K | 0.01% | 448 |
|
|
2025
Q4 | $1.24M | Buy |
25,386
+5,740
| +29% | +$268K | ﹤0.01% | 538 |
|
|
2025
Q3 | $848K | Sell |
19,646
-1,801
| -8% | -$70.3K | ﹤0.01% | 618 |
|
|
2025
Q2 | $824K | Buy |
21,447
+895
| +4% | +$34.2K | ﹤0.01% | 618 |
|
|
2025
Q1 | $796K | Buy |
20,552
+74
| +0.4% | +$2.71K | ﹤0.01% | 606 |
|
|
2024
Q4 | $693K | Sell |
20,478
-624
| -3% | -$22.5K | ﹤0.01% | 662 |
|
|
2024
Q3 | $863K | Sell |
21,102
-670
| -3% | -$27.4K | ﹤0.01% | 599 |
|
|
2024
Q2 | $838K | Sell |
21,772
-853
| -4% | -$35.9K | ﹤0.01% | 577 |
|
|
2024
Q1 | $970K | Sell |
22,625
-2,315
| -9% | -$95.5K | ﹤0.01% | 540 |
|
|
2023
Q4 | $924K | Buy |
24,940
+1,709
| +7% | +$61.4K | ﹤0.01% | 544 |
|
|
2023
Q3 | $842K | Sell |
23,231
-1,518
| -6% | -$53.9K | ﹤0.01% | 523 |
|
|
2023
Q2 | $882K | Sell |
24,749
-919
| -4% | -$33K | ﹤0.01% | 522 |
|
|
2023
Q1 | $913K | Sell |
25,668
-1,100
| -4% | -$38.5K | ﹤0.01% | 498 |
|
|
2022
Q4 | $941K | Sell |
26,768
-2,927
| -10% | -$97.5K | ﹤0.01% | 484 |
|
|
2022
Q3 | $874K | Sell |
29,695
-2,248
| -7% | -$85.2K | ﹤0.01% | 476 |
|
|
2022
Q2 | $1.74M | Buy |
31,943
+568
| +2% | +$31.4K | 0.01% | 377 |
|
|
2022
Q1 | $1.71M | Sell |
31,375
-903
| -3% | -$49K | 0.01% | 398 |
|
|
2021
Q4 | $1.78M | Sell |
32,278
-2,075
| -6% | -$108K | 0.01% | 419 |
|
|
2021
Q3 | $1.64M | Sell |
34,353
-4,554
| -12% | -$229K | 0.01% | 421 |
|
|
2021
Q2 | $1.94M | Buy |
38,907
+765
| +2% | +$36.8K | 0.01% | 389 |
|
|
2021
Q1 | $1.7M | Sell |
38,142
-1,215
| -3% | -$55.1K | 0.01% | 397 |
|
|
2020
Q4 | $1.81M | Sell |
39,357
-3,481
| -8% | -$160K | 0.01% | 376 |
|
|
2020
Q3 | $2.02M | Buy |
42,838
+212
| +0.5% | +$10.6K | 0.01% | 338 |
|
|
2020
Q2 | $2.17M | Sell |
42,626
-1,539
| -3% | -$79K | 0.01% | 320 |
|
|
2020
Q1 | $2.09M | Sell |
44,165
-4,079
| -8% | -$218K | 0.01% | 312 |
|
|
2019
Q4 | $2.83M | Sell |
48,244
-492
| -1% | -$27.4K | 0.02% | 322 |
|
|
2019
Q3 | $2.6M | Sell |
48,736
-4,087
| -8% | -$210K | 0.01% | 322 |
|
|
2019
Q2 | $2.64M | Sell |
52,823
-767
| -1% | -$38.5K | 0.02% | 327 |
|
|
2019
Q1 | $2.8M | Sell |
53,590
-2,515
| -4% | -$126K | 0.02% | 313 |
|
|
2018
Q4 | $2.68M | Sell |
56,105
-4,141
| -7% | -$204K | 0.02% | 308 |
|
|
2018
Q3 | $3.02M | Sell |
60,246
-1,355
| -2% | -$68.8K | 0.02% | 302 |
|
|
2018
Q2 | $3.1M | Sell |
61,601
-3,089
| -5% | -$156K | 0.02% | 293 |
|
|
2018
Q1 | $3.16M | Sell |
64,690
-2,544
| -4% | -$118K | 0.02% | 289 |
|
|
2017
Q4 | $2.98M | Sell |
67,234
-6,643
| -9% | -$307K | 0.02% | 292 |
|
|
2017
Q3 | $3.75M | Sell |
73,877
-3,381
| -4% | -$172K | 0.02% | 276 |
|
|
2017
Q2 | $4.16M | Sell |
77,258
-3,074
| -4% | -$164K | 0.02% | 265 |
|
|
2017
Q1 | $4.23M | Sell |
80,332
-1,696
| -2% | -$86K | 0.03% | 260 |
|
|
2016
Q4 | $3.95M | Sell |
82,028
-8,405
| -9% | -$415K | 0.02% | 271 |
|
|
2016
Q3 | $4.88M | Buy |
90,433
+4,851
| +6% | +$266K | 0.03% | 255 |
|
|
2016
Q2 | $4.64M | Sell |
85,582
-8,764
| -9% | -$462K | 0.03% | 245 |
|
|
2016
Q1 | $4.78M | Sell |
94,346
-14,463
| -13% | -$720K | 0.03% | 239 |
|
|
2015
Q4 | $5.49M | Sell |
108,809
-25,905
| -19% | -$1.32M | 0.04% | 236 |
|
|
2015
Q3 | $6.47M | Sell |
134,714
-19,580
| -13% | -$1.02M | 0.05% | 224 |
|
|
2015
Q2 | $8.03M | Sell |
154,294
-5,318
| -3% | -$299K | 0.05% | 219 |
|
|
2015
Q1 | $9.21M | Sell |
159,612
-24,368
| -13% | -$1.4M | 0.06% | 206 |
|
|
2014
Q4 | $9.83M | Sell |
183,980
-31,595
| -15% | -$1.77M | 0.06% | 195 |
|
|
2014
Q3 | $12.4M | Sell |
215,575
-23,399
| -10% | -$1.43M | 0.08% | 172 |
|
|
2014
Q2 | $16M | Sell |
238,974
-20,501
| -8% | -$1.39M | 0.11% | 161 |
|
|
2014
Q1 | $17.3M | Sell |
259,475
-18,604
| -7% | -$1.26M | 0.13% | 150 |
|
|
2013
Q4 | $18.6M | Sell |
278,079
-17,055
| -6% | -$1.11M | 0.12% | 146 |
|
|
2013
Q3 | $18.5M | Sell |
295,134
-113
| -0% | -$7.27K | 0.13% | 144 |
|
|
2013
Q2 | $18.4M | Buy |
+295,247
| New | +$18.7M | 0.07% | 327 |
|
Other funds holding GSK
JEST
KeyBank National Association's GSK Position: Q2 2026 in Review
KeyBank National Association increased its GSK (GSK) stake by 38% in Q2 2026, buying an estimated $767K and bringing the position to 52,676 shares worth $2.76M. The position accounts for 0.01% of the portfolio, ranked #414.
KeyBank National Association first reported a position in GSK in Q2 2013 and has held it in 53 quarters since. The position peaked at $18.6M in Q4 2013. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.
- KeyBank National Association held 52,676 shares of GSK worth $2.76M as of Q2 2026.
- KeyBank National Association bought 14,506 GSK shares in Q2 2026, an estimated $767K.
- GSK made up 0.01% of KeyBank National Association's portfolio in Q2 2026, its #414 holding.
- KeyBank National Association first reported a position in GSK in Q2 2013 and has held it in 53 quarters since.
- KeyBank National Association's GSK position peaked at $18.6M in Q4 2013.
- 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.
Based on KeyBank National Association's 13F filing for Q2 2026, filed 28 Jul 2026.